BACKGROUND: The most common chromosomal aberration found in meningiomas is monosomy 22. Progression and recurrence of meningiomas are usually associated with additional chromosome losses. Rarely, however, meningiomas have strongly hyperdiploid karyotypes with over 50 chromosomes; the objective of this study was to explore the cytogenetic and histopathologic patterns as well as the clinical significance of hyperdiploidy in meningiomas. METHODS: Within a series of 677 consecutive meningiomas, we identified a subgroup comprising 16 cases that display a strikingly uniform pattern of hyperdiploidy mostly without structural chromosome rearrangements, as shown by banding techniques and, in the single structurally aberrant case, spectral karyotyping. RESULTS: These meningiomas each have between 50 and 56 chromosomes, with trisomy 12 (14/16 cases), trisomy 20 (13/16 cases), trisomy 5 (12/16 cases), and trisomy 17 (10/16 cases). Histomorphologically, hyperdiploid meningiomas feature a heterogeneous phenotype. However, they are associated with a higher histological grade, and decreased expression of alkaline phosphatase as compared to meningiomas with typical karyotype. In two patients, recurrences were documented and three patients died of disease during the period of observation, indicating a worse prognosis of hyperdiploid than of cytogenetically typical meningiomas. CONCLUSION: We conclude that hyperdiploidy constitutes a small but clinically relevant entity of biologically aggressive meningiomas, which are cytogenetically distinguishable from the majority of common-type meningiomas.
BACKGROUND: The most common chromosomal aberration found in meningiomas is monosomy 22. Progression and recurrence of meningiomas are usually associated with additional chromosome losses. Rarely, however, meningiomas have strongly hyperdiploid karyotypes with over 50 chromosomes; the objective of this study was to explore the cytogenetic and histopathologic patterns as well as the clinical significance of hyperdiploidy in meningiomas. METHODS: Within a series of 677 consecutive meningiomas, we identified a subgroup comprising 16 cases that display a strikingly uniform pattern of hyperdiploidy mostly without structural chromosome rearrangements, as shown by banding techniques and, in the single structurally aberrant case, spectral karyotyping. RESULTS: These meningiomas each have between 50 and 56 chromosomes, with trisomy 12 (14/16 cases), trisomy 20 (13/16 cases), trisomy 5 (12/16 cases), and trisomy 17 (10/16 cases). Histomorphologically, hyperdiploid meningiomas feature a heterogeneous phenotype. However, they are associated with a higher histological grade, and decreased expression of alkaline phosphatase as compared to meningiomas with typical karyotype. In two patients, recurrences were documented and three patients died of disease during the period of observation, indicating a worse prognosis of hyperdiploid than of cytogenetically typical meningiomas. CONCLUSION: We conclude that hyperdiploidy constitutes a small but clinically relevant entity of biologically aggressive meningiomas, which are cytogenetically distinguishable from the majority of common-type meningiomas.
Authors: Niko Beerenwinkel; Jörg Rahnenführer; Rolf Kaiser; Daniel Hoffmann; Joachim Selbig; Thomas Lengauer Journal: Bioinformatics Date: 2005-01-18 Impact factor: 6.937
Authors: Niko Beerenwinkel; Jörg Rahnenführer; Martin Däumer; Daniel Hoffmann; Rolf Kaiser; Joachim Selbig; Thomas Lengauer Journal: J Comput Biol Date: 2005 Jul-Aug Impact factor: 1.479
Authors: E P Arnoldus; L B Wolters; J H Voormolen; S G van Duinen; A K Raap; M van der Ploeg; A C Peters Journal: J Neurosurg Date: 1992-06 Impact factor: 5.115
Authors: José María Sayagués; María Dolores Tabernero; Angel Maíllo; Ana Espinosa; Ana Rasillo; Pedro Díaz; Juana Ciudad; Antonio López; Marta Merino; Jesús María Gonçalves; Angel Santos-Briz; Francisco Morales; Alberto Orfao Journal: J Mol Diagn Date: 2004-11 Impact factor: 5.568
Authors: Jörg Rahnenführer; Niko Beerenwinkel; Wolfgang A Schulz; Christian Hartmann; Andreas von Deimling; Bernd Wullich; Thomas Lengauer Journal: Bioinformatics Date: 2005-02-10 Impact factor: 6.937
Authors: M J Bello; J M de Campos; M E Kusak; J Vaquero; J L Sarasa; A Pestaña; J A Rey Journal: Genes Chromosomes Cancer Date: 1994-04 Impact factor: 5.006
Authors: Patrícia Domingues; María González-Tablas; Álvaro Otero; Daniel Pascual; Laura Ruiz; David Miranda; Pablo Sousa; Jesús María Gonçalves; María Celeste Lopes; Alberto Orfao; María Dolores Tabernero Journal: Oncotarget Date: 2015-05-10
Authors: Malak S Abedalthagafi; Parker H Merrill; Wenya Linda Bi; Robert T Jones; Marc L Listewnik; Shakti H Ramkissoon; Aaron R Thorner; Ian F Dunn; Rameen Beroukhim; Brian M Alexander; Priscilla K Brastianos; Joshua M Francis; Rebecca D Folkerth; Keith L Ligon; Paul Van Hummelen; Azra H Ligon; Sandro Santagata Journal: Oncotarget Date: 2014-11-15
Authors: Priscilla K Brastianos; Peleg M Horowitz; Sandro Santagata; Robert T Jones; Aaron McKenna; Gad Getz; Keith L Ligon; Emanuele Palescandolo; Paul Van Hummelen; Matthew D Ducar; Alina Raza; Ashwini Sunkavalli; Laura E Macconaill; Anat O Stemmer-Rachamimov; David N Louis; William C Hahn; Ian F Dunn; Rameen Beroukhim Journal: Nat Genet Date: 2013-01-20 Impact factor: 38.330
Authors: Stefan Linsler; Dennis Kraemer; Christina Driess; Joachim Oertel; Kai Kammers; Jörg Rahnenführer; Ralf Ketter; Steffi Urbschat Journal: PLoS One Date: 2014-04-10 Impact factor: 3.240